Alterola Biotech, Inc. (ABTI)
0.0051
0.00 (0.00%)
USD |
OTCM |
Jan 22, 16:00
Alterola Biotech Cash from Investing (Quarterly): -0.0601M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| NovoCure Ltd. | 71.44M |
| LivaNova Plc | -23.06M |
| Akanda Corp. | -- |
| Kiniksa Pharmaceuticals International Plc | -62.76M |
| Perspective Therapeutics, Inc. | 13.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.6023M |
| Cash from Financing (Quarterly) | 0.142M |